Waning Tdap effectiveness in adolescents

Pediatrics

Volumn 137, Issue 3, 2016, Pages

  Klein, Nicola P ^a   Bartlett, Joan ^a   Fireman, Bruce ^a   Baxter, Roger ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; ETHNICITY; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIORITY JOURNAL; RACE; SEX DIFFERENCE; VACCINATION; VACCINE EFFECTIVENESS; CALIFORNIA; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIPHTHERIA; DISEASE OUTBREAKS; IMMUNIZATION; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TETANUS; WHOOPING COUGH;

ADOLESCENT; CALIFORNIA; CHILD; CONFIDENCE INTERVALS; DIPHTHERIA; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; RETROSPECTIVE STUDIES; TETANUS; VACCINATION; WHOOPING COUGH;

EID: 84960173058     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-3326     Document Type: Article

References (36)

1. Broder KR, Cortese MM, Iskander JK, et al; Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-3):1-34
2. Notes from the Field. Pertussis-California, January-June 2010. MMWR Morb Mortal Wkly Rep. 2010;59(26):817
3. Octavia S, Sintchenko V, Gilbert GL, et al. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J Infect Dis. 2012;205(8):1220-1224
4. Greenberg DP, Doemland M, Bettinger JA, et al; IMPACT Investigators. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanusacellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanusdiphtheriaacellular pertussis vaccine: implications for disease prevention in the United States. Pediatr Infect Dis J. 2009;28(6):521-528
5. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child. 2013;98(7):552-555
6. Barret AS, Ryan A, Breslin A, et al. Pertussis outbreak in northwest Ireland, January-June 2010. Euro Surveill. 2010;15(35):19654
7. Lavine JS, Bjørnstad ON, De Blasio BF, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine. 2012;30(3):544-551
8. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367(11):1012-1019
9. Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308(20):2126-2132
10. Tartof SY, Lewis M, Kenyon C, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 2013;131 (4). Available at: www.pediatrics.org/cgi/content/full/131/4/e1047
11. Sheridan SL, McCall BJ, Davis CA, et al. Acellular pertussis vaccine effectiveness for children during the 2009-2010 pertussis epidemic in Queensland. Med J Aust. 2014;200(6):334-338
12. Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics. 2014;133 (3). Available at: www.pediatrics.org/cgi/content/full/133/3/e513
13. Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013;131 (6). Available at: www.pediatrics.org/cgi/content/full/131/6/e1716
14. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA. 2012;308(5):454-456
15. Liko J, Robison SG, Cieslak PR. Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med. 2013;368(6):581-582
16. Klein NP. Licensed pertussis vaccines in the United States. History and current state. Hum Vaccin Immunother. 2014;10(9):2684-2690
17. Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein NP. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ. 2013;347:f4249
18. California Department of Education. Pertussis (whopping cough) vaccine requirement. 2011. Available at: http://www.cde.ca.gov/ls/he/hn/pertussis.asp. Accessed June 10, 2015
19. Winter K, Glaser C, Watt J, Harriman K; Centers for Disease Control and Prevention (CDC). Pertussis epidemic-California, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(48):1129-1132
20. Koepke R, Eickhoff JC, Ayele RA, et al. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis. 2014;210(6):942-953
21. Acosta AM, De Bolt C, Tasslimi A, et al. Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic. Pediatrics. 2015;135(6):981-989
22. Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015;60(3):333-337
23. Winter K, Glaser C, Watt J, Harriman K; Centers for Disease Control and Prevention (CDC). Pertussis epidemic-California, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(48):1129-1132
24. Skoff TH, Kenyon C, Cocoros N, et al. Sources of infant pertussis infection in the United States. Pediatrics. 2015;136(4):635-641
25. Auger KA, Patrick SW, Davis MM. Infant hospitalizations for pertussis before and after Tdap recommendations for adolescents. Pediatrics. 2013;132 (5). Available at: www.pediatrics.org/cgi/content/full/132/5/e1149
26. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62(7):131-135
27. Cherry JD. Epidemic pertussis and acellular pertussis vaccine failure in the 21st century. Pediatrics. 2015;135(6):1130-1132
28. Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactindeficient Bordetella pertussis in the United States. Clin Vaccine Immunol. 2014;21(2):119-125
29. Martin SW, Pawloski L, Williams M, et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis. 2015;60(2):223-227
30. Pesco P, Bergero P, Fabricius G, Hozbor D. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology. Epidemics. 2014;7:13-21
31. Brüssow H, Sidoti J, Freire WB. Tetanus and diphtheria immunization coverage in Ecuadorian children after a national vaccination campaign. J Infect Dis. 1993;168(2):479-483
32. Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N. Supplementary immunization activities to achieve measles elimination: experience of the European Region. J Infect Dis. 2011;204(suppl 1):S343-S352
33. Simone B, Balasegaram S, Gobin M, et al. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013. Vaccine. 2014;32(36):4681-4688
34. Klaiman T, O'Connell K, Stoto MA. Learning from successful school-based vaccination clinics during 2009 pH1N1. J Sch Health. 2014;84(1):63-69
35. Teixeira AM, Samad SA, Souza MA, Segatto TC, Morice A, Flannery B. Brazilian experience with rapid monitoring of vaccination coverage during a national rubella elimination campaign. Rev Panam Salud Publica. 2011;30(1):7-14
36. Halkyer P, Azurduy R, Fuentes M, Van Dick AM, Ronveaux O. Putting safety first: ensuring safe vaccination practices during the 2006 rubella campaign in Bolivia. J Infect Dis. 2011;204(suppl 2):S718-S721